Article: Accumetrics' aspirin resistance test available in new version.

Accumetrics aspirin resistance test available in new version

By KAREN YOUNG

Medical Device Daily Staff Writer

Accumetrics (San Diego) President and CEO Rob Hillman says there are about 25 million people on an aspirin regimen to prevent platelet aggregation in blood vessels as a way of preventing heart attack or stroke.

But that strategy does not always work, particularly in those patients who are aspirin-resistant, a condition that the company said previous studies have shown is associated with triple the risk of heart attack, stroke and death.

New studies reported at the annual scientific sessions of the American College of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!